UNO, biofire diagnostics, respiratory and gastrointestinal panels suppies, 21F28001, IHS1421933
Ended Awarded Last action
- Contract number
- 75H71221F28001
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $95,827
Award facts
- Contract value 100% obligated
- $95,827.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Duchesne, UT 84026, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,585 | |
| Original award | $99,412 |
About this award
Biofire Diagnostics LLC, a Salt Lake City-based biotechnology company specializing in molecular diagnostic testing solutions, was awarded a Blanket Purchase Agreement (BPA) call valued at $95,827.19 by the Indian Health Service (IHS) for respiratory and gastrointestinal diagnostic panels. This firm fixed-price contract, issued under the parent GSA Schedule for In-Vitro Diagnostics, Reagents, and Tests (FSS-65-VII), was awarded on September 2, 2021, with an ultimate completion date of August 31, 2022. The contract was performed at the Fort Duchesne, Utah location and carried no set-aside designation, reflecting the company's competitive positioning in the federal marketplace. The award represents a closeout contract structure with provisions to de-obligate excess funds.
This contract supports IHS healthcare diagnostic capabilities through Biofire's specialized FilmArray diagnostic systems and associated molecular testing reagents. Biofire Diagnostics maintains a robust federal contract portfolio across multiple healthcare agencies, including the Department of Veterans Affairs, Defense Health Agency, and Department of State, with particular strength in syndromic infectious disease detection. The company holds several significant long-term Indefinite Delivery Vehicles and Blanket Purchase Agreements that enable federal agencies to procure diagnostic products and maintenance services on an as-needed basis, demonstrating the company's established role as a key supplier of advanced diagnostic solutions to federal healthcare systems.
Quick answers
Who was awarded contract 75H71221F28001?
75H71221F28001 was awarded to Biofire Diagnostics LLC by Indian Health Service (Department of Health and Human Services) on September 2, 2021.
How much is contract 75H71221F28001 worth?
The government has obligated $95,827 on 75H71221F28001.
Is contract 75H71221F28001 an order under another contract?
Yes. 75H71221F28001 is a BPA call under V797D30085-75H71221A00011, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75H71221F28001 competed?
The extent of competition for 75H71221F28001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award